Table 1.
A summary of MMP-9 effects in the left ventricle following myocardial infarction
Model | Time of Post-MI Evaluation, days | Cellular Source | MMP-9 Expression | Post-MI Effects |
---|---|---|---|---|
MMP-9 null mice (25, 59, 76) | Up to 28 | Global | ↓ | Deletion: |
↑Neutrophil apoptosis, macrophage phagocytic potential, and neovascularization | ||||
↓Macrophage infiltration, collagen accumulation and LV enlargement and dysfunction | ||||
Transgenic overexpression of MMP-9 in macrophages (105) | 5 | Macrophage | ↑ | Overexpression in macrophages: |
↓Inflammation, macrophage polarization, ECM synthesis, and LV dysfunction | ||||
NF-κB p50 null mice (30) | 56 | Global deletion | ↓ | Deletion: |
↑Early survival | ||||
↓LV dilation | ||||
Diabetic ischemia/reperfusion (5) | 30-min ischemia/2-h reperfusion | Global | ↑ | Diabetes: |
↑Vascular remodeling and cardiovascular complications |
MMP-9, matrix metalloproteinase-9; MI, myocardial infarction; LV, left ventricular; ECM, extracellular matrix.